COMMUNIQUÉS West-GlobeNewswire

Aprea Therapeutics Announces Pricing of Initial Public Offering
03/10/2019
BOSTON, Oct. 02, 2019 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc., a biopharmaceutical company focused on developing and commercializing novel cancer therapeutics that reactivate mutant tumor suppressor protein, p53, [...]
Viela Bio Announces Pricing of Initial Public Offering
03/10/2019
GAITHERSBURG, Md., Oct. 02, 2019 (GLOBE NEWSWIRE) -- Viela Bio, Inc., a clinical-stage biotechnology company pioneering treatments for autoimmune and severe inflammatory diseases, today announced the pricing of its [...]
Organovo Acknowledges Receipt of Proposal
03/10/2019
Reiterates Commitment to Strategic Review Process SAN DIEGO, Oct. 02, 2019 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ: ONVO) (“Organovo”) today confirmed that it has received a proposal from Viscient [...]
Viome Named to the 2019 CB Insights Digital Health 150, List of Most Innovative Digital Health Startups
03/10/2019
Fast-growing healthcare company recognized for achievements in microbiome analysis and chronic disease prevention research SEATTLE, Oct. 02, 2019 (GLOBE NEWSWIRE) -- CB Insights today named Viome to the inaugural [...]
EyePoint Pharmaceuticals Announces Permanent and Specific J-Code for YUTIQ® Now in Effect
02/10/2019
WATERTOWN, Mass., Oct. 02, 2019 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT), a specialty biopharmaceutical company committed to developing and commercializing innovative ophthalmic products, [...]
Aduro Biotech Announces Two Abstracts Accepted for Presentation at the Society for Immunotherapy of Cancer 34th Annual Meeting (SITC 2019)
02/10/2019
BERKELEY, Calif., Oct. 02, 2019 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (NASDAQ: ADRO), a clinical-stage biopharmaceutical company focused on developing therapies targeting the Stimulator of Interferon Genes (STING) and [...]
Lexicon Pharmaceuticals Announces Poster Presentations at the NANETS Annual Multidisciplinary NET Medical Symposium
02/10/2019
THE WOODLANDS, Texas, Oct. 02, 2019 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), announced today that data from five posters highlighting XERMELO ® (telotristat ethyl) will be presented at the [...]
Monthly information regarding the total number of voting rights and total number of shares of the Company
02/10/2019
Monthly information regarding the total number of voting rights and total number of shares of the Company (Article 223-16 of the General Regulations of the Autorité des Marchés Financiers ) Market : NYSE Euronext Paris [...]
Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social
02/10/2019
Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social (Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers) Place de cotation : NYSE Euronext [...]
NÉOVACS ANNONCE SES RÉSULTATS SEMESTRIELS 2019
02/10/2019
COMMUNIQUE DE PRESSE · COMMUNIQUE DE PRESSE · COMMUNIQUE DE PRESSE NÉOVACS ANNONCE SES RÉSULTATS SEMESTRIELS 2019 Paris et Boston, le 2 octobre 2019 – 09 : 30 CEST - NÉOVACS (Euronext Paris : ALNEV, éligible PEA-PME), [...]
NEOVACS ANNOUNCES ITS 2019 HALF-YEAR RESULTS
02/10/2019
PRESS RELEASE PRESS RELEASE · PRESS RELEASE · PRESS RELEASE PRESS RELEASE NEOVACS ANNOUNCES ITS 2019 HALF-YEAR RESULTS Paris and Boston, 2 nd October, 2019— 9:30 p.m. CEST—NEOVACS (Euronext Paris: ALNEV, eligible for [...]
Vital, a Canon Group company, Recognized in Gartner’s Hype Cycle for Real-Time Health System Technologies, 2019 Report
02/10/2019
MINNETONKA, Minn., Oct. 02, 2019 (GLOBE NEWSWIRE) -- Vital, a leading provider in Enterprise Imaging solutions, was named in the Gartner Hype Cycle for Real-Time Health System Technologies, 2019 report 1 . This report [...]
SciCann Therapeutics receives notice of allowance for its enhanced CBD therapy US patent for NASH
02/10/2019
TORONTO and TEL AVIV, Israel, Oct. 02, 2019 (GLOBE NEWSWIRE) -- SciCann Therapeutics is pleased to announce that it has received a notice of allowance from the United States Patent and Trademarks Office (USPTO) for its [...]
‘Medicare for All’ Means Medicare for Nobody, States the Association of American Physicians and Surgeons (AAPS)
02/10/2019
TUCSON, Ariz., Oct. 02, 2019 (GLOBE NEWSWIRE) -- The Medicare in the Sanders Medicare-for-All bill is not the same program that retirees were taxed for their entire working lives, states the Association of American [...]
Allied Corp., a Medical Cannabis Company, Enters Into a Strategic Partnership Giving Access to The European Market
02/10/2019
KELOWNA, British Columbia, Oct. 02, 2019 (GLOBE NEWSWIRE) -- Allied Corp. ("Allied") (OTC: ALID), an international medical cannabis company focused on creating and providing targeted cannabinoid health solutions, is [...]
EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of September 30, 2019
02/10/2019
Disclosure of Share Capital and Voting Rights Outstanding as of September 30, 2019 (Pursuant to Article L.233-8 II of the French Commercial Code and articles 221-1 and 223-16 of the General Regulations of the Autorité [...]
EssilorLuxottica : Nombre total de droits de vote et d’actions composant le capital social au 30 septembre 2019
02/10/2019
Nombre total de droits de vote et d’actions composant le capital social au 30 septembre 2019 (Conformément à l’article L.233-8 II du Code de Commerce et aux articles 221-1 et 223-16 du Règlement Général de l’AMF) [...]
Data on cenerimod – Idorsia's S1P1 receptor modulator – will be presented at the ACR / ARP Annual Meeting 2019
02/10/2019
Allschwil, Switzerland – October 2, 2019 Idorsia Ltd (SIX: IDIA) today announced that data from a Phase 2 study with cenerimod, a selective sphingosine-1-phosphate 1 (S1P 1 ) receptor modulator, will be shared during [...]
bioAffinity Technologies Announces Members of its Scientific and Medical Advisory Board
02/10/2019
SAN ANTONIO, Oct. 02, 2019 (GLOBE NEWSWIRE) -- bioAffinity Technologies , a privately held biotech company, today announced the members of its Scientific and Medical Advisory (SMA) Board who will provide independent [...]

Pages